Biogen Inc (NASDAQ: BIIB)
DRUGS - Biotechnology
Stock price data as of 03/22/2019
Closing price: 216.71
- BIIB is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- BIIB is one of this month's worst performers with a return of -33.4%, underperforming 90 percent of stocks in the S&P-100.
- Down 34.3 percent, BIIB is one of this week's biggest decliners.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 91.7%.
- Volatility is forecast to fall over the next month.
- With RSI < 30, BIIB is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
||Price as % of Range
(Annualized standard deviation)
||Next month forecast
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
- 24.9% in the next week.
- 25.4% in the next month.
- 79.5% in the next year.